Equity Analysis /
United States of America

US : Apellis Pharmaceuticals, Inc. - APLS | 3Q21 Update: PNH Launch Exceeds Expectations; GA Meeting with FDA by YE21

    Contributors
    Timur Ivannikov
    Ryan Deschner
    CGS-CIMB
    9 November 2021
    Published by